TD Cowen Reiterates Buy on Medtronic, Maintains $110 Price Target
9/30/2026
Impact: 80
Healthcare
TD Cowen analyst Joshua Jennings has reiterated a 'Buy' rating on Medtronic (NYSE: MDT) and maintained a price target of $110 for the stock. This endorsement reflects confidence in the company's performance and potential for growth.
AI summary, not financial advice
Share: